Advancing Diabetes Care: Exploring Weekly Insulin Therapy

The ATTD Education Portal is proud to announce The Advancing Diabetes Care: Exploring Weekly Insulin Therapy program, which will provide healthcare professionals with comprehensive training on the evolution of basal insulin therapy, focusing on the transition from daily to weekly insulin formulations.

About the Program

Designed for clinicians at various stages of their careers, this program includes interactive workshops, case-based learning, microlearning modules, and expert-led panel discussions. Participants will gain a deep understanding of weekly insulin’s role in diabetes care, patient selection criteria, dosing strategies, and managing potential adverse effects.

Through real-world case studies and updated clinical insights, this program equips learners with the skills needed to optimize patient outcomes with the latest advancements in insulin therapy.

Program Highlights

🔹 Interactive e-Learning Course: From Daily to Weekly: Understanding the Shift in Basal Insulin Therapy

The introduction of weekly basal insulin requires a change in mindset about insulin therapy. This module builds a foundational understanding, ensuring clinicians are ready for the transition to once-weekly insulin options.

ENROLL HERE

🔹 Live Case-Based Workshop: Transitioning Patients to Weekly Insulin: Case-Based Approaches

This session offers practical, real-world scenarios to guide clinicians in making informed decisions about when and how to initiate weekly basal insulin therapy.

Date: 26 February 2026      Time: 16:00 CET

RESERVE YOUR SPOT

🔹 Branched Scenario E-Learning Course: Managing Hypoglycemia and Adverse Effects in Weekly Insulin Therapy: A Decision-Making Course

Date: March 2026

The branched scenario format offers a more engaging, hands-on learning experience, where learners can explore different decision paths and understand the outcomes of their choices.

🔹 Live Multidisciplinary Roundtable Discussion: Collaborating for Success: A Multidisciplinary Approach to Weekly Insulin Integration

Date: May 2026

A successful diabetes management plan is not only about the insulin therapy itself but about supporting the patient across multiple aspects of care. This roundtable brings together experts from various disciplines to ensure that healthcare professionals are equipped to collaborate effectively and provide well-rounded care for their patients

🔹 Podcast & Webcast Series: The Game-Changing Power of Weekly Insulin

Date: June-August 2026

The series aims to equip HCPs with essential, up-to-date knowledge on weekly insulin therapies. As insulin treatments evolve, this series offers evidence-based insights into their clinical application, patient selection, and management challenges. By focusing on real-world scenarios and multidisciplinary collaboration, the podcast helps clinicians effectively integrate weekly insulin into diabetes care, enhancing patient outcomes and adherence.

🔹Downloadable Resource (PDF guide) + Microlearning Video (5-7 min): Differentiating Weekly Basal Insulin Therapies: A Clinician’s Guide

Date: September/October 2026

As the market will soon feature two distinct weekly basal insulin therapies, it is crucial to equip healthcare professionals with the necessary tools and knowledge to differentiate between them, optimize patient care, and improve treatment outcomes. This session will ensure clinicians are well-prepared for choosing the right therapy based on patient-specific needs and therapy goals.

Learning Outcomes

By the end of this program, learners will be able to:

  • Understand the evolution of basal insulin therapy and the distinct characteristics of weekly insulin.
  • Apply evidence-based patient selection criteria for transitioning to weekly basal insulin therapy.
  • Implement strategies for initiating, titrating, and monitoring weekly insulin therapy.
  • Recognize and manage common adverse effects associated with weekly insulin, such as hypoglycemia.
  • Integrate weekly insulin therapy with other diabetes management approaches, including oral medications and CGM.
  • Stay informed on the latest research, clinical trials, and emerging trends in weekly insulin therapy

Learning Objectives

  • Understand the evolution of basal insulin therapy from daily to weekly formulations.
  • Compare pharmacokinetics and therapeutic benefits between daily and weekly insulins.
  • Discuss patient selection criteria for transitioning to weekly basal insulin therapy.
  • Apply evidence-based strategies for initiating and titrating weekly basal insulin.

Access the Program

All sessions will be available live and on-demand on the ATTD Education Portal.
Start your learning journey today and join thousands of peers advancing diabetes care around the world.

Accredited by: European Accreditation Council for Continuing Medical Education (EACCME)

 

This program is supported by Eli Lilly and Company.